Business Description
AdaptHealth Corp
NAICS : 334510
SIC : 3845
ISIN : US00653Q1022
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.03 | |||||
Equity-to-Asset | 0.32 | |||||
Debt-to-Equity | 1.57 | |||||
Debt-to-EBITDA | -10.89 | |||||
Interest Coverage | 1.78 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 0.37 | |||||
Beneish M-Score | -2.89 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 5.8 | |||||
3-Year EBITDA Growth Rate | -0.1 | |||||
3-Year EPS without NRI Growth Rate | -44.2 | |||||
3-Year FCF Growth Rate | -29 | |||||
3-Year Book Growth Rate | 40.6 | |||||
Future 3-5Y EPS without NRI Growth Rate | 14 | |||||
Future 3-5Y Total Revenue Growth Rate | 5.96 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 64.26 | |||||
9-Day RSI | 57.8 | |||||
14-Day RSI | 54.54 | |||||
6-1 Month Momentum % | 29.04 | |||||
12-1 Month Momentum % | -5.45 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.21 | |||||
Quick Ratio | 1 | |||||
Cash Ratio | 0.14 | |||||
Days Inventory | 16.33 | |||||
Days Sales Outstanding | 41.92 | |||||
Days Payable | 31.33 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -13.9 | |||||
Shareholder Yield % | 2.41 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 14.99 | |||||
Operating Margin % | 7.26 | |||||
Net Margin % | -21.21 | |||||
FCF Margin % | 4.47 | |||||
ROE % | -35.06 | |||||
ROA % | -13.61 | |||||
ROIC % | 4.74 | |||||
ROC (Joel Greenblatt) % | -77.77 | |||||
ROCE % | -13.18 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 12.52 | |||||
PE Ratio without NRI | 42.93 | |||||
PS Ratio | 0.43 | |||||
PB Ratio | 0.93 | |||||
Price-to-Free-Cash-Flow | 9.63 | |||||
Price-to-Operating-Cash-Flow | 2.88 | |||||
EV-to-EBIT | -6.05 | |||||
EV-to-Forward-EBIT | 12.3 | |||||
EV-to-EBITDA | -17.05 | |||||
EV-to-Forward-EBITDA | 5.28 | |||||
EV-to-Revenue | 1.12 | |||||
EV-to-Forward-Revenue | 1.09 | |||||
EV-to-FCF | 25.08 | |||||
Earnings Yield (Greenblatt) % | -16.53 | |||||
FCF Yield % | 10.42 |